- Home
- PMCB vs TLPH Comparison
PMCB vs TLPH Comparison
Compare PMCB & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- TLPH
- Stock Information
- Founded
- PMCB 1996
- TLPH 2005
- Country
- PMCB United States
- TLPH United States
- Employees
- PMCB N/A
- TLPH N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- TLPH Health Care
- Exchange
- PMCB Nasdaq
- TLPH Nasdaq
- Market Cap
- PMCB 15.8M
- TLPH 15.7M
- IPO Year
- PMCB N/A
- TLPH 2011
- Fundamental
- Price
- PMCB $1.77
- TLPH $0.78
- Analyst Decision
- PMCB
- TLPH Strong Buy
- Analyst Count
- PMCB 0
- TLPH 2
- Target Price
- PMCB N/A
- TLPH $4.50
- AVG Volume (30 Days)
- PMCB 37.6K
- TLPH 85.3K
- Earning Date
- PMCB 09-17-2024
- TLPH 11-06-2024
- Dividend Yield
- PMCB N/A
- TLPH N/A
- EPS Growth
- PMCB N/A
- TLPH N/A
- EPS
- PMCB 0.54
- TLPH N/A
- Revenue
- PMCB N/A
- TLPH $398,000.00
- Revenue This Year
- PMCB N/A
- TLPH N/A
- Revenue Next Year
- PMCB N/A
- TLPH N/A
- P/E Ratio
- PMCB $3.31
- TLPH N/A
- Revenue Growth
- PMCB N/A
- TLPH 57.31
- 52 Week Low
- PMCB $1.39
- TLPH $0.43
- 52 Week High
- PMCB $2.58
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- PMCB 48.90
- TLPH 36.51
- Support Level
- PMCB $1.72
- TLPH $0.75
- Resistance Level
- PMCB $2.06
- TLPH $0.99
- Average True Range (ATR)
- PMCB 0.28
- TLPH 0.08
- MACD
- PMCB -0.00
- TLPH -0.01
- Stochastic Oscillator
- PMCB 38.24
- TLPH 22.22
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.